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Abstract: Water soluble homo-base polynucleotide analogues were synthesized in which 
polyvinyl alcohol and partially phosphonated polyvinyl alcohol constituted the backbones, 
onto which were grafted uracil or adenine via 1,3-dioxane spacers formed by acetal 
formation with the 1,3-diol moieties in PVA. The resulting adenine-PVA polynucleotide 
analogs exhibited hyperchromic effects, which was not the case for the corresponding 
uracil compounds. Mixtures of the adenine- and aracil PVA-phosphate polynucleotide 
analogs in solutions exhibited characteristic S-shaped UV-absorbance vs temperature and 
melting curves with melting points at approximately 40 oC. 
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Introduction 
 
Polynucleotides are the biopolymers responsible for the transfer of genetic information in all living 
cells and for the translation of this information for the specific synthesis of proteins required in the 
cells. The synthesis of DNA and RNA analogs are therefore of interest as models in the investigation 
of the relationship between structure and activity, and have recently attracted considerable interest. 
Such analogs have found applications as functional materials [1] and as enzyme mimics [2,3], and 
polynucleotide analogues are also potential anti-viral agents [4]. The use of polymers as agents for 
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non-viral gene delivery is another area attracting increasing interest. This subject was recently 
reviewed by Domb and co-workers [5]. In general DNA can be encapsulated into neutral or anionic 
liposomes. However, as DNA is anionic this was practical merely for DNA of limited size [6]. The 
most common non-viral method applies formation of self-assembled complexes between DNA and 
cationic species [5,7]. 
A number of different polymers have been used as backbones for substitution with nucleobases, 
nucleoside, and nucleotide analogs to constitute polynucleic acid analogs. This has included various 
vinyl polymers based on vinyl acetate, styrene, acryl and methacrylate groups. The early work has 
been reviewed by Inaki [8]. Systems including for example polystyrene [9] and benzene-phosphate 
backbones [10] and phenylpolyacetylene [11] were prepared and their properties studied. Nucleosides 
have also been grafted onto polyethyleneimine [12]. Related to these are the peptidic nucleic acid 
analogs, which were originally studied by Buchardt and co-workers [13-16]. Polyvinyl alcohol, PVA, 
has earlier been used as backbone, onto which modified nucleic bases or nucleoside structure was 
attached for example via amino acid functions [17], carboxylic ester bonds [18] or as phosphate esters 
[20,21].  
Synthetic polymers with attached nucleic bases were reported to have potentially useful properties 
as functional materials, for example as resins for the separation of various biomolecules. Polystyrene 
substituted with Uridine were also reported to be highly active as a galactosyl transferase inhibitor 
[22]. 
 
Results and Discussion 
 
 The objective of this work was the synthesis and studies of new polynucleotide analogs with 
potentially useful properties and applications. The basic concept for these materials was nucleic bases 
attached to a heterocyclic system which were further linked together via methylene groups. Nucleoside 
analogs containing dioxolane rings have been previously synthesized [23] and were reported to display 
broad anti-viral and anti-neoplastic activities [24-26]. Eschenmoser and co-workers have in a series of 
papers reported studies of polynucleotides in which the natural pentose sugars found in DNA and RNA 
were replaced by various hexoses [27-30] or furanosyl heterocycles [31]. 
 In the present work we describe the synthesis of polynucleotide analogs where the more flexible 
heterocyclic 1,3-dioxane system was used as a sugar unit equivalent. In these polynucleotide analogues 
the 1,3-dioxane moiety was integrated into the PVA polymer chain structure. A representative 
structure for the target molecules 1 is shown in Figure 1. The nucleic base pendants in these studies 
were limited to uracil (2), and adenine (3).  
 
Figure 1. 
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Neutral PVA-polynucleotide Analogs 
 
 At first we adopted a preparative procedure for the construction of 1, in which a common 
polymeric intermediate consisting of the PVA backbone was synthesized, in which the 1,3-diole 
groups were converted into 2-bromomethylene-substituted 1,3-dioxane moieties through acetal 
formation with 2-bromodimethoxyethane. This polymeric bromide was next reacted with either uracil 
(2) or adenine (3). Unfortunately, this reaction sequence failed to give satisfactory results.  
 Alternatively, the bases were first converted into 2-substituted acetaldehyde acetals, capable of 
forming 1,3-dioxane rings by transacetal formation with the 1,3-diol moieties in PVA, as described in 
the earlier literature [32]. Thus, uracil (2) was reacted with 2-bromo-1,1-diethoxyethane (4) in the 
presence of NaH in DMF to afford the 1-(2’,2’-diethoxyethyl)-uracil 5. The corresponding adenine 
acetal, 9-(2’,2’-diethoxylethyl)-adenine (6) was prepared in 56 % yield by a similar transformation 
[33] from adenine (3) and 4, using potassium carbonate as the base in DMF, rather than sodium 
hydride. Using sodium hydride as the base resulted in low yields (Scheme 1). 
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 The synthesis of the polymer with appended uracil groups, 1-U, is outlined in Scheme 2. Thus, the 
uracil groups were attached to the PVA backbone through acetal formation, by reacting PVA with 5 in 
the presence of phosphoric acid in water, according to the procedure described earlier by Ichimura et 
al. [34]. The desired homo-polynucleotide analog, 1-U, was thus obtained in 50-60 % yields.  
 By varying the 5 to PVA ratio and reaction times, products were obtained in which the uracil-1,3-
dioxane contents varied from approximately 8 % (1-U8) to 22 % (1-U22), with respect to the calculated 
maximum content (Table 1). In these transformations a PVA grade with a relatively low average 
molecular weight was used, corresponding to an average degree of polymerization of 400 (300 – 500). 
The corresponding Adenine grafted polymers 1-A, were prepared with 6 in 30-40 % yields applying 
the same procedure.  
 The products were purified by precipitation with organic solvents and by dialysis using a dialysis 
membrane with a cut-off at molecular weight 1000. The contents of grafted nucleic bases were 
estimated by NMR and in some cases elemental analyses.  
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Scheme 2. Synthesis of uracil and adenine substituted PVA acetal. 
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   The properties of the products depended on the degree of polymerization of PVA starting 
material and of the content of the base-1,3-dioxane moieties in the products. The same quality of PVA, 
from the same batch, was used in all experiments. The PVA used was readily soluble in water and 
DMSO. 
 
Table 1. Solubility of 1-U and 1-A. 
Polymer 
Base cont. 
% * 
DMSO H2O 
NaH2PO4
0.01 M 
Na3PO4 
0.01 M 
1-U8 8 ++ ++ ++ ++ 
1-U15 15 + - - - 
1-U22 22 + - - - 
1- A9 9 ++ ++ + + 
1-A16 16 ++ + + + 
1-A27 27 ++ - - - 
* The subscript indicates the content of nucleic base-1,3-dioxane moiety 
++ Soluble in the solvent, + Partial soluble, - Not soluble 
  
For the practical applications of the PVA based polynucleotide analogs, solubility was an 
important parameter. Table 1 shows the qualitative results from solubility experiments. Materials 1-U 
and 1-A were not soluble in DMF and acetonitrile, but were to some extent soluble in DMSO and in 
water. With increasing nucleic base contents they exhibited decreasing solubility in distilled water and 
phosphate buffer solutions. This can be rationalized in terms of the marked hydrophobic properties of 
the bases. 
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PVA-polynucleotide Phosphate Analogs 
 
 The data in Table 1 show that the polynucleotide analogs 1-U and 1-A with higher nucleic base 
contents were not readily soluble in water or phosphate buffers. For the purpose of achieving better 
solubility, hydrophilic, anionic groups were introduced in the polymer chain. Therefore partially 
phosphonated PVA was chosen for the polymer backbone. 
  The phosphate ester groups were introduced by reacting PVA with oligophosphoric acid that was 
prepared by adding P2O5 to an excess of 85 % phosphoric acid. This reaction (Scheme 3) was run for 
two days in a desiccator over P2O5. The product was purified by dialysis, precipitated with acetone and 
dried to give the partially phosphonated polyvinyl alcohol, PVA-P [35, 36].  
 
Scheme 3. Preparation of phosphonated PVA. 
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 The content of phosphate groups can be adjusted by changing the stoichiometry of the reaction 
mixtures and reaction time. However, in the subsequent experiment, we used only one grade of PVA-
P, in which approximately 26 % of the hydroxyl groups were converted into phosphate groups, as 
indicated by the P-analysis. The PVA phosphate did not dissolve in any organic solvent but was 
readily soluble in water and aqueous phosphate buffer solutions.  
  
Scheme 4. Synthesis of 7-U and 7-A. 
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This material, PVA-P, was next used for the synthesis of phosphate substituted polynucleotide 
analogs in which the nucleobase-1,3-dioxane moieties were introduced into the partially phosphonate 
substituted polymer backbone, using a similar procedure as described above for the 1-U and 1-A 
analogs. Thus, PVA-P was reacted with 5 or 6 to give polymers 7-U and 7-A respectively (Scheme 4). 
As now, one out of four hydroxy groups was present as phosphoric ester groups, this statistically 
reduced the presence of available 1,3-dihydroxy moieties in the back bone. This can explains why we 
were able to incorporate into the polymer merely 5-8 % of the calculated maximum content of nucleic 
bases in the polymers. Products 7-U and 7-A were similarly purified by precipitation and dialysis. 
  Products 7-U and 7-A were soluble in water and aqueous phosphate buffer solutions, due to the 
hydrophilic phosphate groups grafted onto the PVA backbone. The qualitative solubility of these 
polynucleotide analogs is shown in Table 2. They were readily soluble in water and in aqueous 
phosphate buffers solutions. 
 
Table 2. Solubility of nucleic base analogs containing polyvinyl alcohol phosphate backbone. 
Polymer 
Base cont. 
% * 
DMSO H2O 
NaH2PO4
0.01 M 
Na3PO4 
0.01 M 
PVA-P  - ++ ++ ++ 
7-U8 8 + ++ ++ ++ 
7-A6 6 + ++ ++ ++ 
* The subscript indicates the content of nucleic base-1,3-dioxane moiety 
++ Soluble in the solvent, + Partial soluble, - Not soluble 
 
Temperature Dependent UV spectra of 1-U8, 1-A9, 7-U8 and 7-A6 
 
 DNA and RNA acquire their structures due to the pairing of the nucleic bases through non-
covalent bonding, such as hydrogen bonding. Adenine and thymine, for example, are complementary 
bases which undergo base-pairing through hydrogen bonding. The structure of thymine and uracil are 
very similar, but where the former is found in DNA, uracil is primarily found in RNA. Possible modes 
of base pairing for uracil and adenine involve Watson-Crick and Hoogsteen type structures. Adenosine 
may form a dimer with itself, through similar structural interactions [37,38]. Uracil also forms a dimer 
through hydrogen bond formation [39]. 
 Nucleic bases are highly conjugated molecules, with essentially planar structures. They are 
however hydrophobic, thus interacting unfavorable with water. Consequently, in water, rather than 
having edge to edge interactions through H-bond formation, they prefer to aggregate and stack in 
columns containing a number of bases, due to attractive interactions between the flat faces of the 
bases, owing to van der Waals, dipole-dipole and the various π-interactions. This influences their 
electronic structures, thus electron distributions and light absorption. The close interaction between 
stacked bases causes a decrease in UV absorptions relative to that of solutions of the free nucleotides, 
the so-called hypochromic effect.  
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 During denaturation of DNA, the hydrogen bonds between base pairs and the base stacking are 
interrupted and the double helix structures unwind to form single strands. This usually takes place at 
temperatures above 80 oC. As the hydrogen bonds and stacking is interrupted the UV absorption 
increases – the hyperchromic effect. The result in a characteristic S-shaped absorbance vs. temperature 
curve and defines what is often called the melting point, tm, which is characteristic for the type of DNA 
being studied [40]. 
 The temperature dependency of the UV spectra of selected polynucleotide analogs 1-U8, 1-A9, 7-
U8 and 7-A6 was studied. Despite the substitution structures of these materials presumably being rather 
random and disordered of nature, with statistical distributions of the substituents along the PVA chain, 
surprising distinct hypo- and hyperchromic effects were observed (Figure 2). 
 
Figure 2. The temperature dependency of the UV absorptions at 261 nm for poly-
nucleotide analogs 1-U8, 1-A9, 7-U8 and 7-A6. 
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The hyperchromicity or hypochromicity (approximated as h, %) for these materials was estimated 
using the expression:  
h (%) = ((AT-A0)/ A0) × 100 
where A0 denotes the absorbance at the low temperature and AT the absorbance at the high 
temperature. The results are shown in Table 2. 
 
Table 2. Hyperchromicity and hypochromicity of polymers 1-U8, 1-A9, 7-U8, 7-A6 and a 
1:1 mixture of 7-A6 and 7-U8. 
Polynucleotid
e 
analog 
7-A6 1-A9 1-U8 7-U8 7-A6 + 7-U8 
h (%) 43 7 -2.0 -1.5 57 
 
 The polynucleotide analogs 7-A6 and 1-A8, exhibited hyperchromicity, h, of 43 and 7 % 
respectively. This shows that the pendant phosphate groups in the Adenine series clearly influence the 
Molecules 2008, 13                
        
708
structures of the polymers. Contrary to this, analogs 1-U8 and 7-U8 actually exhibited slight 
hypochromicities, which however may be attributed to lower absorbance due to the thermal expansion 
of the solutions, Figure 2. For 7-A6 and 1-A9, with increasing temperature the UV absorbance increase, 
being a clear indication of decreasing stacking, and consequently, that stacking actually do take place 
for these polynucleotide analogs.  
 The bases are expected to be randomly distributed along the PVA backbone. For polynucleotide 
analogs 7-U8 and 7A6 the presence of the phosphoric ester groups in PVA-P will also affect the 
distribution of the bases. The same PVA-P-batch was used for all experiments. The larger h value 
observed for 7-A6 suggested a larger hyperchromic effect and that stacking was here proved more 
favorable than for 1-A9. If the reduced temperature sensitivity of 1-A9 is real, this may for example be 
rationalized by assuming the presence of adenine-1,3-dioxane clusters along the polymer backbone 
created during the acetal formation with PVA-P by a neighboring group effect due to the adenine-
adenine attractions. No hyperchromicity was detected for the uracil derivatives 1-U8 and 7-U8. This 
tendency was actually in agreement with earlier observations that pyrimidine nucleosides stack less 
readily than the purine nucleosides [41]. Thus, the equilibrium constant at 25 oC for formation of the 
adenosine-adenosine stacked dimer was determined to approximately 5, while the corresponding value 
for the uridine the value was merely 0.6 [42]. The adenine-adenine stacking was studied for dimeric 
structures by Newcomb et al. [39] who established stacking through an observed hypochromicity 
between 15 and 16 %. Strong adenine-adenine stacking was also established by NMR studies of 
oligonucleotides [45-47] and X-ray and theoretical structural studies [43,44]. The corresponding 
uracil-uracil stacking has similarly been studied [48]. 
  
Figure 3. The temperature dependency of the UV absorptions at 261 nm for a 1:1 
mixture of 7-A6 and 7-U8. 
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The UV behavior of mixtures of 7-A6 and 7-U8 in water or aqueous phosphate buffer solutions (pH 
7.0) was investigated, Thus, a buffer solution of 7-A6 at 20 oC (A = 0.900 at 261 nm) was mixed with a 
solution containing the same amount by weight of 7-U8 (A = 0.606). Initially, upon mixing a 
hyperchromic effect was observed as the absorbance increased (A = 1,123), but upon standing at room 
temperature for 3 weeks, the absorbance of this mixture gradually changed corresponding to a 
hypochromic shift relative to the original mixture. Interestingly, when this aged 7-A6 and 7-U8 mixture 
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was then gradually heated to 70 oC, an S-shaped Absorbance vs Temperature curve was obtained, 
(Figure 3) resembling those observed for DNA, although not as sharp as indicated by the slope of the 
deflection tangent. The melting point, tm, was approximately 40 oC. For this 1:1 mixture of 7-A6 and 7-
U8 a yet higher h-value, 57 %, was determined (Table 2). 
Initially, upon mixing 7-A6 and 7-U8, the pairing and stacking of the adenine structures were 
interrupted, due to the interactions with the uracil groups, resulting in an overall hyperchromic effect. 
However, upon standing an increased pairing of the complementary bases slowly took place resulting 
in increasing stacking as indicated by the decreasing UV absorptions. This was a slow process due to 
the disordered and irregular structure of polymers 7-A6 and 7-U8. The overall effect can be understood 
in that bonds between the complementary bases apparently facilitated a more favorable stacking mode 
compared to the pure homo-base polynucleotide analogs. This resembles the annealing process 
observed for complementary strands in DNA.  
  
Figure 4. Proposed structure for possible interactions between 7-A6 and 7-U8. 
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 For these materials, we propose structural elements and interactions as shown in Figure 4. 
Presumably, like in DNA, the polar groups, i.e., HPO4- and OH groups will tend to point towards the 
aqueous medium, away from hydrophobic, base paired region. 
 In solutions all of the materials described above appeared to form aggregates, as their aqueous 
solutions clearly scattered laser light. However, quantitative light scattering experiments were not 
carried out.  
 For the pure samples stored for more than one year under ambient conditions, we observed a 
decrease in solubility, which was ascribed to cross linking of the polymers. It has also previously been 
reported that PVA-phosphates undergo cross linking through phosphate ester formation [36]. The 
soluble fractions of these older materials, however, still exhibited hyper- and hypochromic properties. 
 
Conclusions 
 
  Water soluble homo-base polynucleotide analogues were synthesized in which polyvinyl alcohol 
and partially phosphonated polyvinyl alcohol constituted the backbones, which were grafted which 
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uracil or adenine via 1,3-dioxane spacers formed by acetal formation with the 1,3-diol moieties in 
PVA. The resulting adenine-PVA polynucleotide analogs exhibited marked hyperchromic effects, 
which was not the case, or to a less extend, for the corresponding Uracil compounds. Mixtures of 
adenine- and uracil PVA-phosphate polynucleotide analogs in buffer solutions, after aging, exhibited 
characteristic S-shaped melting curves with melting point at approximately 40 oC. 
 Our assessment of the work presented here, is that interesting and potentially useful synthetic 
procedures were tested out, although with mixed results. Thus, sufficient control was not achieved on 
regioselectivity. In particular, we were not able to obtain complete substituted of PVA. At this point 
control of stereochemistry (cis/trans) was not possible, and the methods allow for the synthesis of 
homo-base polynucleotide analogs only. However, despite these limitations, we observed interesting 
properties, such as hyperchromicity, and mixtures of polymers substituted with complementary bases 
gave indication of paring of polymer strands. 
 
Experimental  
  
General 
 
NMR-spectra were recorded on a Bruker Avance DPX 300 MHz spectrometer or DPX 400 MHz 
spectrometer. TMS was used as an internal standard in the chloroform-d and external standard in the 
deuterated water. The value of δ 2.5 ppm was assigned for DMSO-d6 for experiments in this solvent. 
Infrared spectra were recorded on a Thermo Nicolet FT-IR spectrometer using the Smart Endurance 
reflection cell unit. UV measurements were carried out using a Varian Cary 50 UV-VIS spectrometer 
where the cell was equipped with a thermostat. Dialysis was carried out using Spectra/Por® 6 
membranes with a molecular weight cut-off at 1000. Hypo-, hyperchromicity and melting curves for 
the polynucleotide analogs were determined by measuring the absorbance at 261 nm of the materials 
as a function of temperature for the solutions of these compounds in water or phosphate buffers (pH = 
7.0).  
 
1- (2’,2’-Diethoxyethyl)-uracil (5) [32] 
 
To a stirred suspension of uracil (2.0 g, 18 mmol) in DMF (25 mL) was added sodium hydride 
(0.49 g, 97%, 20 mmol). After stirring for 2 hours at room temperature, the mixture was added drop- 
wise a solution of 2-bromo-1,1-diethoxyethane (7.1 g, 36mmol) in DMF (15 mL) and heated overnight 
at 80°C. An additional portion of 2-bromo-1,1-diethoxyethane (3.54 g, 18 mmol) in DMF (5 mL) was 
then added. The temperature was then raised to 149-150 °C and maintained there for about half an 
hour. The reaction mixture was cooled and the solvent was evaporated under reduced pressure to leave 
a residue, which was extracted with ethyl acetate (60 mL). The extract was filtered, washed with water 
(30 mL), dried over anhydrous sodium sulfate, and evaporated in vacuo to give a yellow oil which 
crystallized upon standing. The crude product was triturated with ether (10 mL) and petroleum ether 
(b.p. 40-60°C, 10 mL), to give 1.83 g (45 %) of the desired product 5. M.p. 92 oC. The product 
exhibited the following spectroscopic properties: 1H-NMR [CDCl3, 300 MHz]: δ 1.22 (t, J= 7.1 Hz, 
6H, CH3), 1.25 (s, 1H, N-H), 3.54 (dq, 2H, J=9.4 Hz, 7.1 Hz, OCH2), 3.77 (dq, 2H, J=9.3 Hz, 7.1Hz, 
Molecules 2008, 13                
        
711
OCH2), 3.79 (d, 2H, J=5.3 Hz, CH2-uracil), 4.62 (t, 1H, 5.3 Hz, -OCH-O), 5.66 (dd, 1H, J=2.3 Hz, 
7.9Hz, C=CH-CO), 7.26 (d, 1H, 2H, J=7.9 Hz, C=CH-N) ppm; 13C-NMR [CDCl3, 75 MHz]: δ 15.3, 
51.0, 64.4, 100.2, 101.6, 146.1, 151.2, 164.0 ppm; IR (neat): 3088, 2977, 2875, 2816, 1705, 1688, 
1612, 1462, 1352, 1251 cm-1. 
 
9-(2’,2’-Diethoxyethyl)-adenine (6) 
 
This compound was prepared in 56 % isolated yield according to the method described in the 
literature [35]. Mp. 203-205 oC. The product exhibited the following spectroscopic properties: 1H-
NMR [CDCl3, 400 MHz]: δ 1.17 (t, J=7.2 Hz, 6H, CH3), 3.49 (dq, 2H, J=9.2 Hz, 7.2 Hz, OCH2), 3.75 
(dq, 2H, J=9.2 Hz, 7.2 Hz, OCH2), 4.29 (d, 2H, J=5.2 Hz, CH2-adenine), 4.74 (t, 1H, 5.2 Hz, -OCH-
O), 7.90 (s, 1H, C8-H), 8.37 (s, 1H, C2-H), 5.78 (broad s, 1H, N-H) ppm; 13C-NMR [CDCl3, 100 
MHz]: δ 15.2, 46.3, 64.0, 100.4, 119.3, 141.8, 150.3, 153.0, 155.4 ppm; IR (neat): 3351, 3113, 3025, 
2978, 2930, 1673, 1602, 1474, 1055 cm-1. 
 
General procedure for the synthesis of adenyl- and uracinyl-1,3-dioxane substituted PVA 
 
PVA (0.36 g) was dissolved in water (26 mL) and added 85 % phosphoric acid (7 mL) and 1-(2',2'-
diethoxyethyl)-uracil, (0.4-1.4 g) or 9-(2',2'-diethoxyethyl)-adenine (0.5-1.5 g) was added. The 
resulting mixture was heated at 80 °C for 3-5 days. The reaction mixture was then cooled to room 
temperature, neutralized to pH 6-7 with sodium carbonate and poured into acetone. The precipitate 
was isolated, washed with acetone and methanol and then subjected to purification by dialysis. The 
product was finally isolated by concentration under reduced pressure, precipitated with acetone and air 
drying.  
By varying the (2',2'-diethoxyethyl) substituted bases, 5 and 6 to PVA ratios and reaction time, varying 
degrees of grafting of base onto the PVA chain was achieved. 
 
Uracinyl-1,3-dioxane substituted PVA (1-U). These products, obtained in 40-50 % yields by the 
reaction of PVA with 5, exhibited the following spectroscopic properties: 1H-NMR [DMSO-d6, 300 
MHz]: δ 1.0-1.87 (-CH2-), 3.0-4.5 (-CH-O, -CH2-uracil, -OH and HOD), 4.71 (O-CH-O), 5.52 (CO-
CH=C-), 7.49 (N-CH=C-), 11.29 (N-H). 13C-NMR [DMSO-d6, 75MHz]/DEPT: δ 146.5 (-CH-), 100.2 
(-CH-), 96.5 (-CH-), 73.3 (-CH-), 72.6 (-CH-), 67.4 (-CH-), 65.5 (-CH-), 63.6 (-CH-), 62.6 (-CH-), 
49.8 (-CH2-), 46.0 (-CH2-), 45.6 (-CH2-), 45.1 (-CH2-), 44.1 (-CH2-), 43.7 (-CH2-) ppm; IR (neat): 
3365, 2917, 1664, 1461, 1251, 1124 cm-1 
 
Adenyl-1,3-dioxane substituted PVA (1-A). These products, obtained in 30-40 % yields by the reaction 
of PVA with 6, exhibited the following spectroscopic properties: 1H-NMR [DMSO-d6, 300 MHz]: δ 
0.95-1.78 (-CH2-), 3.7-4.0(-CH-O), 4.1-4.7 (-CH2-adenine,-OH), 7.25 (NH2), 8.01 (C4-H), 8.15 (C8-
H) ppm; IR (neat): 3319, 3180, 2911, 1635, 1596, 1578, 1416, 1129, 1036 cm-1. 
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Polyvinyl Phosphate (PVA-P). In a beaker, phosphorus pentoxide (80 g) was dissolved in 85 % 
orthphosphoric acid (104 g) and PVA (8.0 g) was added. The mixture was stirred and was placed in a 
dessicator over phosphorus pentoxide to react for two days at room temperature. The reaction mixture 
was stirred several times during this period. The viscous reaction mixture was then diluted with water 
and then dialyzed for 1 to 2 days until the dialysate had essentially the same conductivity as for 
distilled water. The pure dialysate was the concentrated and dried in an oven at 50 °C, to give 4.2 g (46 
%) of product as a film, readily soluble in water. The purified product, PVA-P, exhibited the following 
spectroscopic properties: 13C-NMR [D2O, 75 MHz]: δ 43.8 (-CH2-), 44.3 (-CH2-), 44.5 (-CH2-), 44.9 
(-CH2-), 45.2 (-CH2-), 64.1-65.7 (m,-CH-), 66.4 (-CH-), 66.6 (-CH-), 73.1-76.9 (m, -CH-) ppm; IR 
(neat): 3273, 2919, 1655, 1429, 1191, 951 cm-1; Elemental analysis: C: 36.64 ; H: 6.82; P: 11.68 %. 
 
Adenyl-1,3-dioxane substituted PVA phosphate (7-A). PVA-P (183 mg, 2.8 mmol) and 85% 
phosphorous acid (3.1 g, 26.9 mmol) were dissolved in water (10 mL). The solution was then added 9-
(2’,2’-diethoxyethyl)-adenine (6, 250 mg, 1 mmol) and warmed up to 80 oC. The solution was stirred 
for three days and neutralized with saturated NaHCO3 solution. The solution was dialyzed. The 
dialysate was concentrated under reduced pressure and then air dried to give the product in 50-60 % 
yield as a clear, slightly yellow film, with the following spectroscopic properties: 1H-NMR [D2O, 300 
MHz]: δ 1.1-2.3 (broad, -CH2-), 3.6-4.2 (broad, -CH-O, -CH2-uracil), 4.3-5.1 (b, O-CH-O, -CH-
OPO3H, D2O), 5.8 (CO-CH=C-), 7.6 (N-CH=C-) ppm; IR (neat): 3364, 2916, 2848, 1668, 1461, 1075, 
1028 cm-1. 
 
Uracinyl-1,3-dioxane substituted PVA phosphate (7-U). The above method in which 5 was reacted 
with PVA-P was used. The product 7-U exhibited the following spectroscopic properties: 1H-NMR 
[D2O, 300 MHz]: δ 0.9-2.3 (broad,-CH2-), 3.4-4.1 (broad, -CH-O, -CH2-adenine), 4.1-4.8 (broad, -CH-
OPO3H, D2O), 5.0 (broad, O-CH-O), 8.2 (broad, C4-H, C8-H) ppm; IR (neat): 3309, 2916, 1641, 1601, 
1419, 1229, 1076 cm-1. 
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